Biotechnology company Genzyme Corp. said on Wednesday second-quarter earnings rose nearly 9% on higher sales of its drugs for rare and chronic diseases.
*For more on this story,
Biotechnology company Genzyme Corp. said on Wednesday second-quarter earnings rose nearly 9% on higher sales of its drugs for rare and chronic diseases.
*For more on this story,
Sign-up for our FREE Daily eNews update to get the latest Orange County news delivered right to your inbox!
One-Year for Only $99